[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351963-105":59,"doc-detail-351963-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","immunometabolic-reprogramming-of-fibroblastic-reticular-cells-in-the-tumor-immune-microenvironment-structured-narrative-review","Immunometabolic Reprogramming of Fibroblastic Reticular Cells in the Tumor Immune Microenvironment - Structured narrative review","","Fibroblastic reticular cells (FRCs) function as core stromal components in secondary lymphoid tissues and the tumor immune microenvironment (TIME), where they undergo substantial immunometabolic reprogramming that shapes antitumor immune activity. This structured narrative review synthesizes FRC-driven metabolic changes across multiple cancers, highlighting glucose metabolism, lipid remodeling, and amino-acid metabolism in lung, breast, gastric, lymphoma, head and neck, and melanoma. Hypoxia, nutrient stress, and inflammation promote glycolysis, shift fatty-acid synthesis and oxidation, and perturb amino-acid metabolism, resulting in immunosuppressive metabolite release, cytokine remodeling, and immune-niche formation, enabling targeted immunometabolic therapeutic design.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immunometabolic-reprogramming-of-fibroblastic-reticular-cells-in-the-tumor-immune-microenvironment-structured-narrative-review/351963/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immunometabolic-reprogramming-of-fibroblastic-reticular-cells-in-the-tumor-immune-microenvironment-structured-narrative-review/351963.png","ImageObject",300,407,{"name":92,"@type":93},"Well Done","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the central role of fibroblastic reticular cells (FRCs) in the tumor immune microenvironment (TIME)?","Question",{"text":113,"@type":114},"FRCs are stromal regulators within TIME and secondary lymphoid tissues. Immunometabolic reprogramming in FRCs controls antitumor immune responses by shaping immune niches and metabolic signals.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which metabolic pathways are emphasized in FRC immunometabolic reprogramming across cancers?",{"text":118,"@type":114},"The review emphasizes glucose metabolism, lipid remodeling, and amino-acid metabolism. It links hypoxia and nutrient stress to increased glycolysis, altered fatty-acid synthesis/oxidation, and disrupted amino-acid metabolism.",{"name":120,"@type":111,"acceptedAnswer":121},"How do hypoxia and inflammatory stimulation affect FRCs and downstream immune regulation?",{"text":122,"@type":114},"Under hypoxia, nutrient stress, and inflammation, FRCs enhance glycolysis, remodel lipid handling, and perturb amino-acid metabolism. These changes drive immunosuppressive metabolite secretion, cytokine profile shifts, and the formation of immune niches.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351963,1790164688,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":8,"preview_urls":146},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","BioMed Research International  \nImmunometabolic Reprogramming ofFibroblastic  \nReticular Cells in the Tumor Immune Microenvironment  \nTian Tian1 | Huimin Liu1 | Peiyan Liu1 | Shumin Ye1 | Yudi Wu1, 2 | Jun Zhou1, 2  \n1Department of Pulmonary and Critical Care Medicine, Changzhou Medical Center, Nanjing Medical University, Changzhou City, China | 2Department of  \nPulmonary and Critical Care Medicine, The First People's Hospital of Changzhou, Changzhou City, China Correspondence: Jun Zhou ([czyyzhoujun@njmu.edu.cn](czyyzhoujun@njmu.edu.cn))  \nReceived: 6 February 2026 | Revised: 9 June 2026 | Accepted: 12 June 2026  \nAcademic Editor: Poorani Gurumallesh Prabu  \nKeywords: fibroblastic reticular cell | immunometabolic reprogramming | multiple cancer types | tumor immune microenvironment  \nABSTRACT  \nFibroblastic reticular cells (FRCs), as core stromal cells in secondary lymphoid tissues and the tumor immune microenvironment (TIME), undergo significant immunometabolic reprogramming, which regulates antitumor immune responses. This structured narrative review summarizes the immunometabolic reprogramming of FRCs across various cancers, emphasizing glucose metabolism, lipid remodeling, and amino acid metabolism in lung cancer, breast cancer, gastric cancer, lymphoma, head and neck tumors, and melanoma. Under hypoxia, nutrient stress, and inflammatory stimulation, FRCs enhance glycolysis, alter fatty acid synthesis/oxidation, and disrupt amino acid metabolism, leading to immunosuppressive metabolite secretion, cytokine profile changes, and the formation of immune niches. Understanding these cancer-specific molecular mechanisms can inform targeted immunometabolic therapies.  \n1 | Introduction  \nThe advent of cancer immunotherapy, particularly the successful clinical application of immune checkpoint inhibitors [1–3], has revolutionized the treatment of multiple advanced malignancies [4] . However, the overall efficacy is limited, and the majority of patients experience primary or secondary resistance [5–7], which remain significant challenges in clinical practice. Essentially, tumors not only establish an immunosuppressive microenvironment at the primary site but also hinder the initiation of antitumor immune responses at the systemic level. The key site for this process is the tumor-draining lymph nodes (TdLNs) [8], which act as the origin and regulatory center of adaptive immune responses.  \nTdLNs [9–12] are the initial sites where naive T cells recognize tumor antigens, become activated, and differentiate into effector T cells. The efficiency and quality of this process directly determine the quantity and function of T cells that subsequently  \ninfiltrate the tumor. In the T cell area of TdLNs, there exists a highly specialized stromal cell—fibroblastic reticular cell (FRC)[13–16]—which forms a fine three-dimensional reticular structure. Traditionally, it was believed to be a physical scaffold for the migration and interaction of T cells and dendritic cells. However, research over the past decade has completely revolutionized this understanding: FRCs are active and indispensable regulators of the microenvironment in B and T-cell areas. Besides forming a reticular scaffold that guides the migration of immune cells, under steady-state conditions, they support the survival and homeostasis of naive T cells and memory T cells by secreting CCL19 [17], CCL21 [18], CXCL12 [19], and IL-7 [20–22] and providing metabolic substrates such as lactate [23] . During the tumor development and progression, the dynamic interaction between tumor cells and the immune microenvironment drives significant functional remodeling of FRCs. Metabolic reprogramming, as the core regulatory mechanism of cellular functional transformation, has become a key entry point for understanding the role ofFRCs in tumor immunity.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any","cbCaibLN7STipms7","https://ap.wps.com/l/cbCaibLN7STipms7","pdf",942989,"English","# Introduction\n## Tumor-draining lymph nodes and FRC roles\n## Metabolic reprogramming as a regulatory mechanism\n# Methodology\n## Structured narrative review and literature search","[{\"question\":\"What is the central role of fibroblastic reticular cells (FRCs) in the tumor immune microenvironment (TIME)?\",\"answer\":\"FRCs are stromal regulators within TIME and secondary lymphoid tissues. Immunometabolic reprogramming in FRCs controls antitumor immune responses by shaping immune niches and metabolic signals.\"},{\"question\":\"Which metabolic pathways are emphasized in FRC immunometabolic reprogramming across cancers?\",\"answer\":\"The review emphasizes glucose metabolism, lipid remodeling, and amino-acid metabolism. It links hypoxia and nutrient stress to increased glycolysis, altered fatty-acid synthesis/oxidation, and disrupted amino-acid metabolism.\"},{\"question\":\"How do hypoxia and inflammatory stimulation affect FRCs and downstream immune regulation?\",\"answer\":\"Under hypoxia, nutrient stress, and inflammation, FRCs enhance glycolysis, remodel lipid handling, and perturb amino-acid metabolism. These changes drive immunosuppressive metabolite secretion, cytokine profile shifts, and the formation of immune niches.\"}]","Immunometabolic Reprogramming of Fibroblastic Reticular Cells in the Tumor Immune Microenvironment - Structured narrative review | PDF",1790096625,23,[147],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/0521de185a7a16359f9e35f5161f5d86.webp",983,1291]